Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Armando Villarreal

Pain Medicine Rochester, NY Medical Doctor

NPI 1992806525 CMS profile 362834

601 Elmwood Ave, Rochester, NY 14642

Open in the dashboard

General payments

$19,346

142 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$14,230 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Armando Villarreal of Rochester, NY is reported in the CMS Open Payments database as having received $19,346 across 142 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $14,230 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 90th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,164 19
2024 General $7,409 32
2023 General $3,679 35
2022 General $3,417 29
2021 General $314 3
2019 General $3,363 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Armando Villarreal
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Armando Villarreal were reported at $1,164. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Armando Villarreal Pain Medicine median Middle half National median
2019 $3,363 $498 $126–$1,682 $163
2020 $0 $284 $80–$910 $114
2021 $314 $399 $112–$1,219 $132
2022 $3,417 $455 $137–$1,484 $149
2023 $3,679 $484 $128–$1,495 $160
2024 $7,409 $498 $131–$1,540 $164
2025 $1,164 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $12,966 89 payments
  2. Nevro Corp. $3,531 24 payments
  3. Saluda Medical Americas, Inc. $1,502 9 payments
  4. Spinal Simplicity, LLC $440 6 payments
  5. Abbott Laboratories $366 7 payments
  6. Boston Scientific Corporation $174 2 payments
  7. RIWOspine, Inc. $147 1 payment
  8. Medtronic USA, Inc. $124 3 payments
  9. SPR Therapeutics, Inc $97 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,135 113 payments
  2. Travel and Lodging $6,865 25 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,225 3 payments
  4. Education $122 1 payment
Products named General payments · program years 2019–2025
  1. INTELLIS ADAPTIVESTIM $10,532 74 payments
  2. Senza Spinal Cord Stimulation System $3,142 20 payments
  3. VANTA ADAPTIVESTIM $1,712 5 payments
  4. Evoke SCS $1,502 9 payments
  5. HA MINUTEMAN G3-R $440 6 payments
  6. Omnia $389 4 payments
  7. INCEPTIV $351 4 payments
  8. PROCLAIM $351 6 payments
  9. INTELLIS $211 2 payments
  10. Intracept $174 2 payments
  11. Other $542 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

157

Median for Anesthesiology: 322

Drug cost

$1,433

Median for Anesthesiology: $8,738

Branded share of claims

23.6%

Median for Anesthesiology: 25.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 37 $668
Ibuprofen Generic 34 $428
Gabapentin Generic 21 $186
Cyclobenzaprine Hcl Generic 36 $84
Tramadol Hcl Generic 29 $67

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,517 Part D prescribers listed as Anesthesiology; they describe a distribution and say nothing about conduct.

Records

142 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record